Skip to content

Jerry L. Fischer, MD, PHD

NPI 1376654780ActiveIndividual· Internal Medicine, Nephrology· Omaha, NE

Internal Medicine, Nephrology (MD, PHD) in Omaha, Nebraska, licensed in NE, with an NPI issued in August 2006. Part D covered 17 prescriptions written in 2024, 71% of them generic. Gilead Sciences, Inc. reported $28.90 in payments in 2024, mostly food and beverage.

Overview

NPI1376654780
StatusActive
Entity typeIndividual
CredentialMD, PHD
Sole proprietorNo
NPI issuedAug 31, 2006
Last updated in NPPESApr 10, 2019

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Nephrology Primary207RN0300X13846NE

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)17 · 31 30-day fills
Patients11
Total drug cost$2,578
Generic share71% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$28.90 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Gilead Sciences, Inc.$28.901

What the 2024 payments were for

  • Food and Beverage$28.90 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Nephrology providers in Omaha

All Internal Medicine, Nephrology providers in Nebraska →